ClinConnect ClinConnect Logo
Search / Trial NCT06818734

Implementation of a Clinical Decision Support Tool for Postpartum Depression

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Feb 7, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Clinical Decision Support Tool

ClinConnect Summary

This clinical trial is studying a new tool that helps doctors identify women who may be at risk for postpartum depression (PPD) after giving birth. Postpartum depression is a common condition that can affect new mothers, and this study aims to improve the way healthcare providers can detect it early using an automated system in their electronic health records. This tool could make it easier for doctors to recognize signs of PPD and offer support to those who need it.

To participate in the trial, women must be at least 18 years old, currently pregnant (at least 20 weeks along), and receiving care at one of the participating clinics. Unfortunately, women who do not speak English or lack internet access will not be able to join. Participants can expect to be involved in a study that aims to improve care for new mothers. It's also important to know that the trial is not yet recruiting participants, which means they are still in the planning stages.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18 years or older
  • being seen at one of participating clinics
  • pregnancy at 20 week gestation or more
  • Exclusion Criteria:
  • Does not speak inclusion
  • does not have internet access
  • Clinician eligibility:
  • If they manage patients in the three clinics as a board-certified OBGYN clinician.
  • No exclusion criteria apply for clinician based on their knowledge and experience in treating PPD

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

Brooklyn, New York, United States

New York, New York, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Yiye Zhang, PhD

Principal Investigator

Weill Medical College of Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported